The AAT-AD/PD™ 2020 Focus Meeting took place on April 2-5, 2020, and was held as an entirely virtual meeting. The event was scheduled to take place in Vienna (Austria) but the coronavirus crisis has prompted the organisers to take extraordinary measures.
Lectures were held from remote locations and posters were shared virtually from the virtual meeting lobby. The conference gathered clinical investigators and scientists who presented and discussed all the latest breakthroughs in treatment, translational Research & Development, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.
We were glad than an AMYPAD abstract was accepted as a short oral of poster presentation. Daniele Altomare (UNIGE) presented the baseline features of the first participants enrolled in the AMYPAD Diagnostic and Patient Management Study (DPMS).
You can still take part in the AAT-AD/PD™ 2020 program! If you are interested to access the online sessions (available until 30 June), you can register here.
For more information on the conference, please visit: https://aat-adpd.kenes.com/
Mark your agenda for next year! The 15th International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders, AD/PD™ 2021, will be held from March 9-14 in Barcelona (Spain).
Follow us on Twitter: @IMI_AMYPAD
Receive the latest news. Click here to subscribe!